Cargando…
A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice
Dystrophin-deficient muscles experience large reductions in expression of nitric oxide synthase (NOS), which suggests that NO deficiency may influence the dystrophic pathology. Because NO can function as an antiinflammatory and cytoprotective molecule, we propose that the loss of NOS from dystrophic...
Autores principales: | Wehling, Michelle, Spencer, Melissa J., Tidball, James G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150800/ https://www.ncbi.nlm.nih.gov/pubmed/11581289 http://dx.doi.org/10.1083/jcb.200105110 |
Ejemplares similares
-
Arginine Metabolism by Macrophages Promotes Cardiac and Muscle Fibrosis in mdx Muscular Dystrophy
por: Wehling-Henricks, Michelle, et al.
Publicado: (2010) -
Targeting a therapeutic LIF transgene to muscle via the immune system ameliorates muscular dystrophy
por: Welc, Steven S., et al.
Publicado: (2019) -
Neuronal Nitric Oxide Synthase-Rescue of Dystrophin/Utrophin Double Knockout Mice does not Require nNOS Localization to the Cell Membrane
por: Wehling-Henricks, Michelle, et al.
Publicado: (2011) -
Whole Body Periodic Acceleration Is an Effective Therapy to Ameliorate Muscular Dystrophy in mdx Mice
por: Altamirano, Francisco, et al.
Publicado: (2014) -
Supplementation with a selective amino acid formula ameliorates muscular dystrophy in mdx mice
por: Banfi, Stefania, et al.
Publicado: (2018)